Antidepressants and suicidal behaviour in late life: a prospective population-based study of use patterns in new users aged 75 and above

European Journal of Clinical Pharmacology

Volumn 74, Issue 2, 2018, Pages 201-208

  Hedna, Khedidja ^a   Andersson Sundell, Karolina ^b,c   Hamidi, Armina ^a   Skoog, Ingmar ^a   Gustavsson, Sara ^a   Waern, Margda ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Aged; Antidepressants; Cohort study; Pharmacoepidemiology; Suicide

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; HYPNOTIC AGENT; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; NOOTROPIC AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; COHORT ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK ASSESSMENT; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; SWEDISH CITIZEN; VERY ELDERLY; EPIDEMIOLOGY; PROTECTION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SWEDEN;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; MALE; NOOTROPIC AGENTS; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK FACTORS; SUICIDE; SUICIDE, ATTEMPTED; SWEDEN;

EID: 85032807892     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-017-2360-x     Document Type: Article

References (47)

1. Statistics Sweden (2016) Statistics on Causes of Death 2015 [In Swedish]. http://www.socialstyrelsen.se/publikationer2016/2016-8-4. Accessed 17 Aug 2017
2. Bertolote JM, De Leo D (2012) Global suicide mortality rates—a light at the end of the tunnel? Crisis 33(5):249–253
3. Beautrais AL (2002) A case control study of suicide and attempted suicide in older adults. Suicide Life Threat Behav 32(1):1–9
4. Barbui C, Esposito E, Cipriani A (2009) Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. Can Med Assoc J 180(3):291–297
5. Gibbons RD, Hur K, Bhaumik DK, Mann JJ (2005) The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62(2):165–172
6. Parikh C (2000) Antidepressants in the elderly: challenges for study design and their interpretation. Br J Clin Pharmacol 49(6):539–547
7. Cadieux RJ (1999) Antidepressant drug interactions in the elderly: understanding the P-450 system is half the battle in reducing risks. Postgrad Med 106(6):231–249
8. Reynolds CF III, Frank E, Kupfer DJ, Thase ME (1996) Treatment outcome in recurrent major depression: a post hoc comparison of elderly (“young old”) and midlife patients. Am J Psychiatry 153(10):1288
9. Lapierre S, Erlangsen A, Waern M, De Leo D, Oyama H, Scocco P, Gallo J, Szanto K, Conwell Y, Draper B (2011) A systematic review of elderly suicide prevention programs. Crisis 32(2):88–98
10. Conwell Y, Duberstein PR, Caine ED (2002) Risk factors for suicide in later life. Biol Psychiatry 52(3):193–204
11. Erlangsen A, Canudas-Romo V, Conwell Y (2008) Increased use of antidepressants and decreasing suicide rates: a population-based study using Danish register data. J Epidemiol Community Health 62(5):448–454
12. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:d4551
13. Vaughn McCall W, Benca RM, Rosenquist PB, Riley MA, McCloud L, Newman JC, Case D, Rumble M, Krystal AD (2017) Hypnotic medications and suicide: risk, mechanisms, mitigation, and the FDA. Am J Psychiatry 174(1):18–25
14. Lodhi LM, Shah A (2004) Psychotropic prescriptions and elderly suicide rates. Med Sci Law 44(3):236–244
15. Carlsten A, Waern M (2009) Are sedatives and hypnotics associated with increased suicide risk of suicide in the elderly? BMC Geriatr 9:20
16. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A (2009) The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24(11):659–667
17. Ray WA (2003) Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 158(9):915–920
18. Wettermark B, Hammar N, Michael Fored C, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726–735
19. Swedish National Board of Health and Welfare (2016) The National Patient Register. http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish. Accessed 17 Aug 2017
20. WHO Collaborating Centre for Drug Statistics Methodology (2012) Guidelines for ATC classification and DDD assignment 2013. Oslo
21. Lesén E, Petzold M, Andersson K, Carlsten A (2009) To what extent does the indicator “concurrent use of three or more psychotropic drugs” capture use of potentially inappropriate psychotropics among the elderly? Eur J Clin Pharmacol 65(6):635–642
22. Choudhry NK, Shrank WH, Levin RL, Lee JL, Jan SA, Brookhart MA, Solomon DH (2009) Measuring concurrent adherence to multiple related medications. Am J Manag Care 15(7):457–464
23. Nemeroff CB, Goldschmidt-Clermont PJ (2012) Heartache and heartbreak—the link between depression and cardiovascular disease. Nat Rev Cardiol 9(9):526–539
24. Erlangsen A, Stenager E, Conwell Y (2015) Physical diseases as predictors of suicide in older adults: a nationwide, register-based cohort study. Soc Psychiatry Psychiatr Epidemiol 50(9):1427–1439
25. Brown PJ, Roose SP, Fieo R, Liu X, Rantanen T, Sneed JR, Rutherford BR, Devanand D, Avlund K (2014) Frailty and depression in older adults: a high-risk clinical population. Am J Geriatr Psychiatry 22(11):1083–1095
26. Fässberg MM, Cheung G, Canetto SS, Erlangsen A, Lapierre S, Lindner R, Draper B, Gallo JJ, Wong C, Wu J (2016) A systematic review of physical illness, functional disability, and suicidal behaviour among older adults. Aging Ment Health 20(2):166–194
27. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496–509
28. Grimes DA, Schulz KF (2002) Bias and causal associations in observational research. Lancet 359(9302):248–252
29. National Board of Health and Welfare (2016). National guidelines for care of depression and anxiety disorders: support for control and management [In Swedish]. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/20405/2016-12-6.pdf. Accessed 22 Aug 2017
30. Waern M, Runeson BS, Allebeck P, Beskow J, Rubenowitz E, Skoog I, Wilhelmsson K (2002) Mental disorder in elderly suicides: a case-control study. Am J Psychiatry 159(3):450–455
31. Wiktorsson S, Runeson B, Skoog I, Östling S, Waern M (2010) Attempted suicide in the elderly: characteristics of suicide attempters 70 years and older and a general population comparison group. Am J Geriatr Psychiatry 18(1):57–67
32. Fässberg MM, Östling S, Börjesson-Hanson A, Skoog I, Wærn M (2013) Suicidal feelings in the twilight of life: a cross-sectional population-based study of 97-year-olds. BMJ Open 3(2):e002260
33. Cox E, Martin BC, Van Staa T, Garbe E, Siebert U, Johnson ML (2009) Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II. Value Health 12(8):1053–1061
34. Waern M (2003) Alcohol dependence and misuse in elderly suicides. Alcohol Alcohol 38(3):249–254
35. Gorman JM (1996) Comorbid depression and anxiety spectrum disorders. Depress Anxiety 4(4):160–168
36. Sherbourne CD, Wells KB (1997) Course of depression in patients with comorbid anxiety disorders. J Affect Disord 43(3):245–250
37. Jonson M, Skoog I, Marlow T, Fässberg MM, Waern M (2012) Anxiety symptoms and suicidal feelings in a population sample of 70-year-olds without dementia. Int Psychogeriatr 24(11):1865–1871
38. Waern M, Marlow T, Morin J, Östling S, Skoog I (2013) Secular changes in at-risk drinking in Sweden: birth cohort comparisons in 75-year-old men and women 1976–2006. Age Ageing 43(2):228–234
39. Keks N, Hope J, Keogh S (2016) Switching and stopping antidepressants. Aust Prescr 39(3):76–83
40. Philip NS, Carpenter LL, Tyrka AR, Price LH (2010) Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era. Expert Opin Pharmacother 11(5):709–722
41. Miller CH, Fleischhacker WW (2000) Managing antipsychotic-induced acute and chronic akathisia. Drug Saf 22(1):73–81
42. Poyurovsky M (2010) Acute antipsychotic-induced akathisia revisited. Br J Psychiatry 196(2):89–91
43. Olsson P, Wiktorsson S, Sacuiu S, Marlow T, Östling S, Fässberg MM, Skoog I, Waern M (2016) Cognitive function in older suicide attempters and a population-based comparison group. J Geriatr Psychiatry 29(3):133–141
44. Erlangsen A, Zarit SH, Conwell Y (2008) Hospital-diagnosed dementia and suicide: a longitudinal study using prospective, nationwide register data. Am J Geriatr Psychiatry 16(3):220–228
45. Erlangsen A, Agerbo E, Hawton K, Conwell Y (2009) Early discontinuation of antidepressant treatment and suicide risk among persons aged 50 and over: a population-based register study. J Affect Disord 119(1):194–199
46. Hansen DG, Rosholm J-U, Gichangi A, Vach W (2007) Increased use of antidepressants at the end of life: population-based study among people aged 65 years and above. Age Ageing 36(4):449–454
47. National Board of Health and Welfare (2016). Statistical database for causes of death [In Swedish]. http://www.socialstyrelsen.se/statistik/statistikdatabas/dodsorsaker. Accessed 17 Oct 2017